You just read:

Poseida Therapeutics Presents High-Fidelity Genome Editing System for Production of Allogeneic "Universal Donor" CAR-T Cells at American Society of Clinical Oncology Annual Meeting

News provided by

Poseida Therapeutics, Inc.

Jun 05, 2017, 08:00 ET